Zura Bio (ZURA) appointed Eric Hyllengren as CFO, effective July 7. He will succeed Verender Badial, who will step down from the role and remain with the company as a non-executive employee through July 31, 2025, to support a seamless transition. Badial joined Zura Bio in March 2023, at the time of its business combination with JATT Acquisition. Hyllengren most recently served as COO and CFO at Atara Biotherapeutics. He previously spent 15 years at Amgen.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZURA:
- Zura Bio participates in a conference call with Piper Sandler
- Zura Bio Highlights Pipeline Progress at Jefferies Conference
- Zura Bio to Present at Jefferies Healthcare Conference
- Zura Bio Holds Annual General Meeting of Shareholders
- Zura Bio’s Strategic Advancements and Promising Clinical Trials Support Buy Rating